124 related articles for article (PubMed ID: 24323398)
1. Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells.
Anderson KM; Guinan P; Rubenstein M
Med Oncol; 2014 Jan; 31(1):779. PubMed ID: 24323398
[TBL] [Abstract][Full Text] [Related]
2. The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.
Anderson KM; Guinan P; Rubenstein M
Anticancer Res; 2011 Feb; 31(2):487-94. PubMed ID: 21378328
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Stokke T; Nesland JM; Suo Z
PLoS One; 2011; 6(12):e29170. PubMed ID: 22216200
[TBL] [Abstract][Full Text] [Related]
4. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
[TBL] [Abstract][Full Text] [Related]
5. PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.
Zhang K; Waxman DJ
Mol Cancer; 2010 Dec; 9():319. PubMed ID: 21190562
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
7. Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.
Yan X; Tang B; Chen B; Shan Y; Yang H;
Elife; 2019 Mar; 8():. PubMed ID: 30860027
[TBL] [Abstract][Full Text] [Related]
8. MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.
Li X; Zhong Y; Lu J; Axcrona K; Eide L; Syljuåsen RG; Peng Q; Wang J; Zhang H; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Oncotarget; 2016 Jun; 7(26):40297-40313. PubMed ID: 27248169
[TBL] [Abstract][Full Text] [Related]
9. CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells.
Johansson E; Grassi ES; Pantazopoulou V; Tong B; Lindgren D; Berg TJ; Pietras EJ; Axelson H; Pietras A
Cell Rep; 2017 Aug; 20(7):1641-1653. PubMed ID: 28813675
[TBL] [Abstract][Full Text] [Related]
10. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson KM; Jajeh J; Guinan P; Rubenstein M
Anticancer Res; 2009 Nov; 29(11):4579-88. PubMed ID: 20032407
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.
Krishnamachary B; Penet MF; Nimmagadda S; Mironchik Y; Raman V; Solaiyappan M; Semenza GL; Pomper MG; Bhujwalla ZM
PLoS One; 2012; 7(8):e44078. PubMed ID: 22937154
[TBL] [Abstract][Full Text] [Related]
13. Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.
Su J; Xu XH; Huang Q; Lu MQ; Li DJ; Xue F; Yi F; Ren JH; Wu YP
Arch Med Res; 2011 Jan; 42(1):15-21. PubMed ID: 21376257
[TBL] [Abstract][Full Text] [Related]
14. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
[TBL] [Abstract][Full Text] [Related]
15. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules.
Ramteke A; Ting H; Agarwal C; Mateen S; Somasagara R; Hussain A; Graner M; Frederick B; Agarwal R; Deep G
Mol Carcinog; 2015 Jul; 54(7):554-65. PubMed ID: 24347249
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
[TBL] [Abstract][Full Text] [Related]
17. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
Gupta A; Cao W; Chellaiah MA
Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells.
Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N
Cells; 2019 Feb; 8(2):. PubMed ID: 30754655
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
Wei C; Guomin W; Yujun L; Ruizhe Q
Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
[TBL] [Abstract][Full Text] [Related]
20. Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma.
Huang P; Wang CY; Gou SM; Wu HS; Liu T; Xiong JX
World J Gastroenterol; 2008 Jun; 14(24):3903-7. PubMed ID: 18609717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
